Baird lowered the firm’s price target on Idex Corp. (IEX) to $226 from $232 and keeps an Outperform rating on the shares. Maximize Your ...
Q4 2024 Management View CEO Eric Ashleman highlighted strong performance in Q4 2024, with notable achievements in the Health & Science Technologies (HST) segment, including impactful projects in ...